Restricted mean survival time analysis to assess efficacy and safety of intensive vs standard blood pressure treatment goals as a function of age: insights from the SPRINT trial

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Hypertension: epidemiology, targets and comorbidities Clinical ESC Premium Access ESC Congress 2019

ESC 365 is supported by

ESC 365 is supported by